RESUMEN

A study of a new regimen of insulin comatose therapy by intravenous instillation has shown the feasibility of determining the minimal comatose dose of insulin and achieving the comatose state in the first days of insulin therapy. This method makes it possible to utilize the advantages of insulin comatose treatment (a more marked arresting antipsychotic action and the remission persistence). At the same time insulin comatose therapy by intravenous instillation permits the physicians to overcome one of the major drawbacks of this treatment, namely the time lag of the therapeutic response associated with the period of time needed to select the minimal comatose dose which was characteristic of the old method.

Asunto(s)

Terapia Convulsiva/métodos , Insulina/administración & dosificación , Esquizofrenia/terapia , Adulto , Glucemia/análisis , Humanos , Infusiones Parenterales , Inyecciones Subcutáneas